Innovation

Biologically Active Agents Encapsulated in Biodegradable Starch/Polymer Matrices

University of Kansas
posted on 10/03/2005

"This formulation uses native, denatured starch and synthetic, biocompatible polymers to protect the active agent by encapsulating it. Exposure to the biological environment allows slow degradation of the encapsulating matrix and extended release of the agent. "

Suggested Uses

Veterinary surgical implantsPesticidesHerbicidesFertilizers

Innovation Details
 

Detailed Description

Compounds to be released into biological environments can be subject to loss by degradation, dilution, leaching, or evaporation. The loss of effectiveness increases costs and may result in contamination of the surrounding environment. It is often desirable to extend the period of release. This formulation uses native, denatured starch and synthetic, biocompatible polymers to protect the active agent by encapsulating it. Exposure to the biological environment allows slow degradation of the encapsulating matrix and extended release of the agent. The particulate formulation can be made in any particle size distribution for spreading and cultivation, and it can be slurried for wet application without altering the release properties of the formulation. The type and proportion of biopolymers can be changed to adjust the release time and pattern as desired.

File Number: FY 92 

Other Information: *State of Development* All fields of use available for license.Lab release tests completed. Soil tests completed.Rainfall/runoff tests completed.


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Jim Baxendale at University of Kansas for more information.

request more info
People

Case Manager:

Icon_avatar Jim Baxendale

Innovations (48)

Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

3,941 members 11,891 innovations 107 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...